Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
High Blood Pressure Strategy (HBPS)
This study is currently recruiting participants.
Verified by Heart and Stroke Foundation of Ontario, August 2008
Sponsors and Collaborators: Heart and Stroke Foundation of Ontario
Sunnybrook Health Sciences Centre
Information provided by: Heart and Stroke Foundation of Ontario
ClinicalTrials.gov Identifier: NCT00446914
  Purpose

This program developed by the HSFO aims at helping people of Ontario and their primary healthcare providers better diagnose, manage and control high blood pressure. The High Blood Pressure Strategy brings together healthcare providers and patients to improve the way in which family doctors, nurse practitioners and pharmacists work together and with patients towards improved control of high blood pressure through the use of evidence-informed tools combined with local systems change.


Condition Intervention
Hypertension
Behavioral: Systems Change (High Blood Pressure Strategy)

MedlinePlus related topics: High Blood Pressure
U.S. FDA Resources
Study Type: Interventional
Study Design: Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title: High Blood Pressure Strategy: Hypertension Management Initiative Study

Further study details as provided by Heart and Stroke Foundation of Ontario:

Primary Outcome Measures:
  • Blood Pressure [ Time Frame: 36 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 5000
Study Start Date: January 2007
Estimated Study Completion Date: January 2010
Estimated Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)
Detailed Description:

Approximately 5,000 patients will participate in the study at 11 family practice sites throughout Ontario. Each of the 11 clinic sites will be randomised to either intervention or delayed intervention 9 months later. The intervention is a systems change involving interprofessional education and management tools to bring together physicians, nurses and pharmacists with the patient. Patients will be monitored by their family doctor or nurse practitioner at scheduled follow-up visits during a period of 36 months for an effect of the intervention over time on the patient's blood pressure.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adults aged 18 years or older
  • History of elevated BP reading or primary hypertension diagnosis

Exclusion Criteria:

  • Major mental health illness of cognitive impairment
  • Language barrier (unable to speak or read English)
  • Lives in a long-term care home
  • Secondary hypertension
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00446914

Contacts
Contact: Sheldon W Tobe, MD, FRCP(C) 416-480-6901 sheldon.tobe@sunnybrook.ca

Locations
Canada, Ontario
Heart and Stroke Foundation of Ontario Recruiting
Toronto, Ontario, Canada, M4P1E4
Contact: Margaret Moy Lum-Kwong, BSc.N, MBA, CHE     416-489-7111 ext 445     moylumkwong@hsf.on.ca    
Contact: Shirley Von Sychowski, BA, MA     416-489-7111 ext 339     svsychowski@hsf.on.ca    
Sponsors and Collaborators
Heart and Stroke Foundation of Ontario
Sunnybrook Health Sciences Centre
Investigators
Principal Investigator: Sheldon W Tobe, MD, FRCP(C) Sunnybrook Health Sciences Centre
Principal Investigator: Margaret Moy Lum-Kwong, BSc.N., MBA, CHE Heart and Stroke Foundation of Ontario
Principal Investigator: Shirley Von Sychowski, BA, MA Heart and Stroke Foundation of Ontario
  More Information

Responsible Party: Sunnybrook Health Sciences Centre ( Sheldon Tobe )
Study ID Numbers: 474-2006
Study First Received: March 12, 2007
Last Updated: August 18, 2008
ClinicalTrials.gov Identifier: NCT00446914  
Health Authority: Canada: Ethics Review Committee

Keywords provided by Heart and Stroke Foundation of Ontario:
Hypertension
Blood Pressure

Study placed in the following topic categories:
Vascular Diseases
Hypertension

Additional relevant MeSH terms:
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009